Israel Englander’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Israel Englander’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-54,807	Closed	-$19K	–	4578
2018 Q2	$19K	Buy	+54,807	New	+$45K	﹤0.01%	3736
2018 Q1	–	Sell	-65,770	Closed	-$93K	–	4405
2017 Q4	$93K	Buy	+65,770	New	+$108K	﹤0.01%	3669
2016 Q4	–	Sell	-222,630	Closed	-$1.08M	–	4056
2016 Q3	$1.08M	Sell	222,630 -13,442	-6%	-$61.3K	﹤0.01%	2234
2016 Q2	$779K	Buy	236,072 +114,255	+94%	+$431K	﹤0.01%	2282
2016 Q1	$432K	Buy	+121,817	New	+$628K	﹤0.01%	2595

Other funds holding ARLZ

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Israel Englander's ARLZ Position: Q3 2018 in Review

Israel Englander sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 54,807 shares — an estimated $19K sold.

Israel Englander first reported a position in ARLZ in Q1 2016 and held it in 5 quarters. The position peaked at $1.08M in Q3 2016. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

Israel Englander reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
Israel Englander sold 54,807 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $19K.
Israel Englander first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 5 quarters.
Israel Englander's Aralez Pharmaceuticals Inc. position peaked at $1.08M in Q3 2016.
4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Millennium Management's 13F filing for Q3 2018, filed 14 Nov 2018.